Successful outcome prompts early end to sickle cell anemia clinical trial
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute ...
Nov 19, 2014
0
0